1982
DOI: 10.1016/0024-3205(82)90293-4
|View full text |Cite
|
Sign up to set email alerts
|

The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

10
62
0

Year Published

1983
1983
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 230 publications
(72 citation statements)
references
References 9 publications
10
62
0
Order By: Relevance
“…[ 3 H]Nitrendipine binding to cortical membranes was measured by a modification of the method of Ehlert et al (1982). The final pellet had been resuspended in 50mM Tris-HCl buffer (pH 7.4).…”
Section: [ 3 H]nitrendipine Bindingmentioning
confidence: 99%
“…[ 3 H]Nitrendipine binding to cortical membranes was measured by a modification of the method of Ehlert et al (1982). The final pellet had been resuspended in 50mM Tris-HCl buffer (pH 7.4).…”
Section: [ 3 H]nitrendipine Bindingmentioning
confidence: 99%
“…Voltage-dependent calcium channels that mediate functions of smooth muscle and cardiac muscle and neural tissue are blocked by calcium channel-antagonist drugs (15,16 (18,19). The DPBPs display structural similarities to verapamil-like drugs (Fig.…”
mentioning
confidence: 99%
“…The pharmacological effects of 1,4-DHP calcium antagonists are due to an interaction with specific receptors in the cardiovascular system. The binding properties of calcium antagonists to these receptors were characterized extensively in vitro in brain, myocardial, and smooth muscles (Bellemann et al, 1981;Bolger et al, 1982;Ehlert et al, 1982;Gould et al, 1982;Godfraind et al, 1986). However, the in vitro receptor affinities of calcium antagonists may not reflect the pharmacological activity and the tissue selectivity in vivo of these drugs because the in vitro binding technique does not take various pharmacokinetic (absorption, distribution, elimination) and pharmacodynamic factors into account.…”
Section: Introductionmentioning
confidence: 99%